6 next given, viz., 0 * 45 grm. in two days, then after a week, 0 * 3 grm. in two days, followed by the same doses at the same intervals. The red cells were thus kept at about six millions and the hmmoglobin at about 120%, and there was no increase in the van den Bergh reaction to any extent, although it ranged round one unit of indirect pigment. After giving no drug for a month, the red cells were once more over eight millions, and the hemoglobin 140%.
The blood-pressure, which was 160/115 before the initial treatment, fell to 100/75. It is now rising again.
It will be seen from these observations that adequate doses of phenylhydrazine will cause a fall in the red cells, but at the expense of rather violent blood destruction. Small doses, often repeated, will restrain the tendency for the count to return to its usual high level. But that tendency is always there, and it remains to be seen whether it is feasible to give a potent protoplasmic poison, such as this drug is, indefinitely.
DISCUSSION ON THE USE OF NIRVANOL IN THE
TREATMENT OF CHOREA. Dr. Bernard Schlesinger: At the moment we have no right to speak of nirvanol as in any way a cure for acute rheumatism, but its effect in certain cases is so remarkably beneficial that further trial and investigation of its mode of action are fully warranted.
The general effect of nirvanol may apparently be produced in nearly every patient and not merely in the rheumatic subject.
In most cases, from eight to fourteen days after a daily oral administration of 0-25 to 03 grm., a well-marked morbilliform eruption appears, usually accompanied by pyrexia. The temperature may be considerable for several days, rising as high as 1040 F. in some instances, but in the majority of my cases moderate or quite mild degrees of pyrexia were observed, and at times the patients remained afebrile throughout. The rash which, in tinge and character, bears a certain resemblance both to morbilli and rubella, may best be described as falling between these two exanthemata. Occasionally it may assume a scarlatinal or an urticarial form. After about four or five days the eruption disappears, leaving behind no trace and not being followed by desquamation. There are few subjective svmptoms, beyond a mild pharyngitis and cervical adenitis in some cases, and slight drowsiness and headache in others. The rash may irritate slightly, but in most instances there is no complaint whatever, even when marked pyrexia is present.
Administration of the drug produces almost constant changes in the blood, of which the most important is a true eosinophilia. In addition there is generally a leucopenia, with decrease in the polymorphonuclear cells, and a relative lymphocytosis and monocytosis. The alteration in the blood-count is only temporary, and when the reaction is over and the drug is stopped, the blood picture gradually becomes normal. A number of cases have no febrile reaction and no rash, but only show an eosinophilia, while some patients do not react at all.
Treatment of Chorea.-For the successful treatment of chorea by this drug one must aim at producing a nirvanol reaction. With this in view a sufficiently large dose must be given, but at present this is empirical, and there is as yet no means of regulating the severity of the reaction. I have used a daily dose of 0 3 grm. for children of from 9 to 14 years of age, with a correspondingly smaller quantity below this age (about 0 * 25 grm. from 6 to 9 years). It is wise never to exceed a daily dose of 0 3 grm., and I have found this sufficient to produce a typical reaction in a woman aged 20. The drug must be stopped immediately a rash or sudden pyrexia appears, and if this has not occurred by the twelfth day it is useless and even dangerous to proceed with the treatment.
In most cases the effect of the drug on chorea is very striking. Just before the onset of the reaction, i.e., usually after about a week or ten days of treatment, the choreic manifestations are aggravated, but with the disappearance of the rash they subside with dramatic rapidity, and are generally almost entirely arrested within a week or ten days. This improvement bears no relation to the stage of the acute chorea at which the treatment was begun, and it appears possible to cut short the illness at any time. I have found that the most successful cases have been those with the most marked reactions, and I have failed to influence the course of the disease when, in addition to the non-appearance either of pyrexia or a rash, eosinophilia has not occurred. Even with a typical reaction, nirvanol may fail, especially in an obstinate case of subacute chorea. The most dramatic improvement is generally seen in the severest and most acute cases, but I have also had successful results with this drug in long-standing chronic cases, which other previous therapeutic measures had failed to influence.
The treatment has not been long enough in practice for us to form any opinion as to the ultimate prognosis, or to gather whether the common liability to subsequent attacks is prevented. Relapses have been reported at varying intervals after the first successful nirvanol treatment, and I have seen two such cases. Should this occur nirvanol will again arrest the chorea, although with this second course the only obvious signs of a reaction is an eosinophilia, and the rash and temperature are not encountered.
Although all the cases I have treated have run a mild and unalarming course, it is only fair to mention that dangerous and deleterious effects of the drug have been reported. For example, Keller describes a case in which a secondary reaction occurred eleven days after the first one, in which gingivitis, tonsillitis, stomatitis, nephritis, jaundice, blood-stained diarrhoea, swelling of the face and cndematous ulceration of the upper lip occurred. Fortunately the patient ultimately recovered. There was some reason to believe that this formidable secondary reaction was brought on by accidental exposure to sunlight. This may have been a coincidence, but since another severe secondary reaction has been reported after giving artificial sunlight to a patient who had just finished his course of nirvanol, it appears wise to guard against such rays for two or three weeks after this form of therapy.
One other clinical manifestation may cause alarm during administration of the drug in a bad case of chorea. Aggravation of the symptoms just before the reaction occurs has already been alluded to, and when the chorea is associated with much mental excitement and hysteria, the mental instability also may be temporarily increased. This occurred in one case to such a degree that the child's mentality was completely altered for a week or more, but after this temporary and somewhat alarming phase the boy became normal again and has remained so since.
Judging from the many accounts from various independent sources, since Roeder's original communication in 1919, nirvanol certainly seems to be a potent drug which is effective in chorea and has the advantage of oral administration.
Against this is the fact that there is a small element of risk in the treatment, and for this reason it may be considered unjustifiable to take such heroic measures to combat a self-curable disease.
Realizing this criticism, I have for the last few months devoted my attention to a further aspect of the question, and have endeavoured' to discover whether the drug is merely anti-choreic, or alternatively, cotuld in-any way be termed anti-rheumatic. Treatment of Acute and Subacute Rheumatism.-We are all agreed that one of the most obvious manifestations of activity of a rheumatic infection is the presence of nodules and I have been able to watch the effect of the drug in six such cases. I shall endeavour to show that nirvanol seems to have a striking effect both on the smouldering temperature and rapid pulse-rate that may be present, and also on the nodules, causing them to disappear with a remarkable rapidity.
Since, however, nodules may arise in one night and disappear with almost equal rapidity, we must not be led astray and in our enthusiasm substitute " propter " for "post," and, without question, eulogize the drug. Cases have been chosen, therefore, in which the nodules were obstinately persistent and had been observed for a considerable period before the drug was administered.
The results in several cases of this type are very suggestive, if not absolutely convincing; nirvanol commonly has the power of making most of the nodules vanish at about the time of the reaction to the drug, whilst usually one or two, after diminishing to a marked degree, still persist for some weeks until they also finally disappear.
The termination of a persistent mild degree of pyrexia and tachycardia is additional evidence of the beneficial action of the drug against the infection.
In one of the severest of my cases, in which there were very large and widespread nodules, administration of nirvanol caused the nodules and other signs of rheumatic activity to disappear in a striking manner, but the infection was only temporarily suppressed, and fresh manifestations of rheumatism appeared soon afterwards with a return of nodules. A second course of nirvanol acted like the first, the temperature and pulse-rate dropped immediately, and, after a slightly longer interval, the nodules almost disappeared. The rheumatic infection, however, had not been entirely overcome, so that a few nodules persisted and the pulse-rate gradually rose again. A third course of nirvanol was given, and the patient now seems to be well on the road to complete recovery. Nirvanol has certainly failed to influence the rheumatic process in other similar cases.
Nevertheless, after observing these cases, one cannot help feeling that nirvanol, if wisely administered, has a healing effect not only in cases of chorea but also in acute and subacute rheumatism in general.
It is not unlikely that Aschoff's nodes in the myocardium are also made to vanish, seeing that their larger cousins under the skin are influenced in such a striking fashion. Clinically the signs of endocarditis have not been observed to alter under this form of treatment, but one would not expect much change in an old-established lesion. On the other hand, in one or two cases in which the carditis was more acute, the area of cardiac dullness was found to diminish at the same time as other signs of rheumatic activity subsided after the nirvanol treatment.
How the drug acts is still a complete mystery. A possible hypothesis is that it whips up the patient's natural powers of defence. For the moment we can only regard the use of nirvanol as an interesting piece of empirical therapeutics which seems worthy of further study.
Dr. F. J. Poynton: My attention was drawn to nirvanol by Dr. Schlesinger in May, 1929. Since then I have been intent upon studying its effect on chorea, and am now commencing with slow caution to make further investigations upon other rheumatic manifestations and forms of rheumatism.
I regard most cases of chorea as rheumatic, and, though I am not entirely satisfied on the point, I believe that a rheumatic meningo-encephalitis is the best pathological explanation. It follows that in its active treatment there are two lines of approach. The first is the treatment of chorea as a rheumatic lesion. I have tried most of the anti-rheumatic drugs, anti-sera and vaccines, and both combined, during the past twenty-five years, and I have not convinced myself of a specific remedy.
The other practical line is the treatment of the nervous disturbances. Here again I have tried numerous drugs. For a long time I thought chloral and bromide the most useful, but lately I have settled upon chloretolne as rather better.
There are two points to which I would allude. One is that chorea, like all other cardinal manifestations of rheumatism, is very variable in both severity and course, and consequently, I look upon reports of successful treatment based upon a few cases as of no essential value, but accept the well-known generalization that acute cases tend to get well more rapidly than the subacute. The other, an important one, i3 that though I have had many hundreds of cases of chorea under my observation, I have only known two patients die from chorea alone. Some few I have seen nearly die, and we all know that chorea and carditis may be fatal. The purport of this is, that if we treated our cases of chorea by rest and nursing, few, if any, of the patients would die, and that remedies which are in themselves dangerous adventures are not applicable to the condition. This was my attitude when nirvanol was brought to my notice, and I decided to try it after a study of the evidence put before me, because there appeared good support of its direct effect upon the nervous symptoms, and also because its remarkable effects upon the blood and general condition made it reasonable to believe that it might have a deeper influence upon rheumatic processes than one could realize without personal trial. I was fully aware of possible complications. Up to the present, although I have used it in about thirty cases, I have never had any reason for anxiety, but have, as yet, never departed from a dosage of 0 3 grm. per diem for a child aged 9 years, and 0 * 25 for a child under 9, given orally, half in the morning and half in the evening. When the rash appeared I always stopped the treatment, and when the rash did not appear I never continued the treatment beyond the fourteenth day. The general reactions in my cases corresponded with those described. There was in one case a fleeting jaundice, but I have seen jaundice with chorea on more than one occasion long before using this drug, and am not prepared to say it was due in this case to the drug, but made a mental note of the occurrence. I have had a good many cases in which there have been no rash and no obvious reaction. These have improved, but less definitely than those in which there has been good reaction. I have seen two relapses in cases in which there has not been a reaction, and though each time they improved under the treatment, in the second course they gave no more sign of reaction than in the first. Whether this drug prevents future attacks when in the first instance it has produced a definite reaction and a good result, it is too early yet to say. It is not easy to assess its value, for the reason that the symptoms often increase before the tenth day, and then the quiet after the storm naturally produces a somewhat dramatic effect upon one's consciousness. I am nevertheless of opinion that recovery is more rapid, and that the child becomes steady sooner, than under any other treatment I have used. The nurses in my children's wards have been impressed, and they are good observers, but only weight of evidence and time will give us a sure answer. I intend at present to continue its use and cautiously explore its possible value in other rheumatic lesions and rheumatic disorders. I believe that it acts on the nervous-rather than on the rheumatic factors-of the disease, but I am approaching its clinical study with an entirely open mind and with only one precaution, which is to do nothing reckless.
Dr. Terence East: The following three cases illustrate the effects of nirvanol in the treatment of chorea:
(I) A girl, aged 12. Severe case with chorea for many months. At first 0-15 grm. was given twice daily for four days. Then the dose was increased to 0 * 225 grm. twice daily for three days, and then to O -3 grm. twice daily for another three days. During this time the chorea increased; when the rash appeared the drug was stopped. Preceding the appearance of the rash, the heart rate rose during three days. Two days after the nirvanol reaction there were pains in the limbs, and the temperature went up but was speedily controlled by salicylates. Afterwards the chorea was very much less, but was still present. In this case the typical reaction was preceded by a steady increase in the rate of the heart, and was followed by an exacerbation of rheumatism. In all 2 65 grin. of nirvanol was given in nine days.
(II) A woman, aged 20. Dosage at first 0 15 grm. twice daily. Increased to 0 26 grm. twice daily after four days. On the eleventh day the patient became very drowsy. During the preceding days the chorea had become much less and the heart rate had slowed. On the thirteenth day the drowsiness diminished, and further doses of 0 15 grm. twice daily were given for seven days. During this time all trace of chorea disappeared. Eosinophil count, 6 * 6%. This patient had no fever and no rash, so that it is possible for a good result to be obtained from nirvanol without provoking the reaction. In this case 5 *46 grm. in all were given.
(III) A boy, aged 8. Here 0 15 grm. was given daily, in two doses of 0 * 075 grm. After seven days (0 * 95 grm. in all having been given) drowsiness appeared, and the rash came out on the following day with a rise of temperature. During the administration of the drug there was a steady increase in the heart rate, which finallv reached 160, when the fever was 101 * 4. The chorea then diminished and the patient was cured.
These three cases illustrate the varied effects which may be produced by the administration of nirvanol. Although good results may be obtained, the use of the drug requires the closest supervision and care, until more is known about it.
[Charts of the cases were shown on the screen.]
